171 related articles for article (PubMed ID: 33190261)
21. Primary cutaneous Epstein-Barr virus-positive diffuse large B-cell lymphoma: a rare and aggressive cutaneous lymphoma.
Vermeesch J; Ramirez J; Lafond A
Cutis; 2018 Dec; 102(6):421-424. PubMed ID: 30657800
[TBL] [Abstract][Full Text] [Related]
22. Diffuse large B-cell non-Hodgkin's lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Tilly H; Dreyling M;
Ann Oncol; 2008 May; 19 Suppl 2():ii67-9. PubMed ID: 18456774
[No Abstract] [Full Text] [Related]
23. Diagnosis of 'double hit' diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC.
Swerdlow SH
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):90-9. PubMed ID: 25696840
[TBL] [Abstract][Full Text] [Related]
24. Primary cutaneous B-cell lymphomas- clinical and histopathologic features, differential diagnosis, and treatment.
Chen ST; Barnes J; Duncan L
Semin Cutan Med Surg; 2018 Mar; 37(1):49-55. PubMed ID: 29719020
[TBL] [Abstract][Full Text] [Related]
25. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.
Drexler HG; Gignac SM; von Wasielewski R; Werner M; Dirks WG
Leukemia; 2000 Sep; 14(9):1533-59. PubMed ID: 10994999
[TBL] [Abstract][Full Text] [Related]
26. Diffuse large B-cell lymphoma: is morphologic subdivision useful in clinical management?
Salar A; Fernández de Sevilla A; Romagosa V; Domingo-Claros A; González-Barca E; Pera J; Climent J; Grañena A
Eur J Haematol; 1998 Mar; 60(3):202-8. PubMed ID: 9580245
[TBL] [Abstract][Full Text] [Related]
27. Natural history of follicular grade 3 non-Hodgkin's lymphoma.
Bierman PJ
Curr Opin Oncol; 2007 Sep; 19(5):433-7. PubMed ID: 17762566
[TBL] [Abstract][Full Text] [Related]
28. Lymphomas arising in immune-privileged sites: insights into biology, diagnosis, and pathogenesis.
King RL; Goodlad JR; Calaminici M; Dotlic S; Montes-Moreno S; Oschlies I; Ponzoni M; Traverse-Glehen A; Ott G; Ferry JA
Virchows Arch; 2020 May; 476(5):647-665. PubMed ID: 31863183
[TBL] [Abstract][Full Text] [Related]
29. Diffuse aggressive lymphoma.
Fisher RI; Miller TP; O'Connor OA
Hematology Am Soc Hematol Educ Program; 2004; ():221-36. PubMed ID: 15561685
[TBL] [Abstract][Full Text] [Related]
30. Advances in Diagnosis and Management of Diffuse Large B-cell Lymphoma.
Cabanillas F; Shah B
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):783-796. PubMed ID: 29126866
[TBL] [Abstract][Full Text] [Related]
31. Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.
Ollila TA; Olszewski AJ
Curr Treat Options Oncol; 2018 Jun; 19(8):38. PubMed ID: 29931605
[TBL] [Abstract][Full Text] [Related]
32. EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management.
Castillo JJ; Beltran BE; Miranda RN; Young KH; Chavez JC; Sotomayor EM
Am J Hematol; 2016 May; 91(5):529-37. PubMed ID: 27093913
[TBL] [Abstract][Full Text] [Related]
33. Double hit lymphoma: How do we define it and how do we treat it?
Merron B; Davies A
Best Pract Res Clin Haematol; 2018 Sep; 31(3):233-240. PubMed ID: 30213392
[TBL] [Abstract][Full Text] [Related]
34. Breast lymphomas: a clinicopathologic review.
Bobrow LG; Richards MA; Happerfield LC; Diss TC; Isaacson PG; Lammie GA; Millis RR
Hum Pathol; 1993 Mar; 24(3):274-8. PubMed ID: 8454272
[TBL] [Abstract][Full Text] [Related]
35. The management of newly diagnosed large B-cell lymphoma: A British Society for Haematology Guideline.
Fox CP; Chaganti S; McIlroy G; Barrington SF; Burton C; Cwynarski K; Eyre TA; Illidge T; Kalakonda N; Kuhnl A; McKay P; Davies AJ
Br J Haematol; 2024 Apr; 204(4):1178-1192. PubMed ID: 38247115
[No Abstract] [Full Text] [Related]
36. [Mediastinal large B-cell lymphoma].
Barth TF; Möller P
Pathologe; 2007 Feb; 28(1):36-40. PubMed ID: 17195039
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of bcl-6, CD10 and CD38 immunoreactivity in stage I-II gastric lymphomas: identification of a subset of CD10+ large B-cell lymphomas with a favorable outcome.
Ponzoni M; Ferreri AJ; Pruneri G; Pozzi B; Dell'Oro S; Pigni A; Pinotti G; Villa E; Freschi M; Viale G; Capella C
Int J Cancer; 2003 Aug; 106(2):288-91. PubMed ID: 12800208
[TBL] [Abstract][Full Text] [Related]
38. Large B cell lymphoma--year by year.
Syed AS; Samad FA; ur Rahman M
J Ayub Med Coll Abbottabad; 2007; 19(4):121-6. PubMed ID: 18693614
[TBL] [Abstract][Full Text] [Related]
39. A Review of Primary Thyroid Lymphoma: Molecular Factors, Diagnosis and Management.
Pavlidis ET; Pavlidis TE
J Invest Surg; 2019 Mar; 32(2):137-142. PubMed ID: 29058491
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management.
Wilcox RA
Am J Hematol; 2018 Nov; 93(11):1427-1430. PubMed ID: 30039522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
